$PULM -- Just inked 22million upfront for 50% on their most pronounced product-line with a leading Indian pharma company, where the market for Pur1900 is likely $100M-$1B+. Their IP is applicable to all kinds of medicines in the same fashion, they need the world to see P2/P3 results and to commercialize -- and Pulmatrix will be a $1B market cap company+ in due time.
IMO
All comments are solely my opinion. Please formulate your own opinion and act on your own accord on all actions you take.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.